These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36325995)

  • 1. The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey.
    Reynolds LM; Barnett B; Weleff J; Morunga E; Wells A; Stack A; Akroyd A; Hoeh N; Sundram F; Muthukumaraswamy S; Lawrence N; Evans WJ
    Palliat Support Care; 2022 Nov; ():1-10. PubMed ID: 36325995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiritual health practitioners' contributions to psychedelic assisted therapy: A qualitative analysis.
    Peacock C; Mascaro JS; Brauer E; Zarrabi AJ; Dunlop BW; Maples-Keller JL; Grant GH; Raison CL; Rab F; Palitsky R
    PLoS One; 2024; 19(1):e0296071. PubMed ID: 38166057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care.
    Ross S; Agrawal M; Griffiths RR; Grob C; Berger A; Henningfield JE
    Neuropharmacology; 2022 Sep; 216():109174. PubMed ID: 35772523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.
    Beaussant Y; Tulsky J; Guérin B; Schwarz-Plaschg C; Sanders JJ;
    J Palliat Med; 2021 Nov; 24(11):1657-1666. PubMed ID: 33848208
    [No Abstract]   [Full Text] [Related]  

  • 5. Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.
    Niles H; Fogg C; Kelmendi B; Lazenby M
    BMC Palliat Care; 2021 Dec; 20(1):191. PubMed ID: 34930220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients.
    Wells A; Muthukumaraswamy APS; Morunga E; Evans W; Cavadino A; Bansal M; Lawrence NJ; Ashley A; Hoeh NR; Sundram F; Applebaum AJ; Parkinson H; Reynolds L
    Pilot Feasibility Stud; 2024 Feb; 10(1):29. PubMed ID: 38347582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Healthcare Workers' Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation.
    Reynolds LM; Akroyd A; Sundram F; Stack A; Muthukumaraswamy S; Evans WJ
    Int J Environ Res Public Health; 2021 Aug; 18(15):. PubMed ID: 34360453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.
    Palitsky R; Kaplan DM; Peacock C; Zarrabi AJ; Maples-Keller JL; Grant GH; Dunlop BW; Raison CL
    JAMA Psychiatry; 2023 Jul; 80(7):743-749. PubMed ID: 37256584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
    Barnett BS; Parker SE; Weleff J
    Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives.
    Beaussant Y; Sanders J; Sager Z; Tulsky JA; Braun IM; Blinderman CD; Bossis AP; Byock I
    J Palliat Med; 2020 Oct; 23(10):1323-1334. PubMed ID: 32233936
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada.
    Argento E; Goldenberg S; Deering K; Lavalley J; Braschel M; Bingham B; Shannon K
    Drug Alcohol Depend Rep; 2022 Jun; 3():100044. PubMed ID: 36845985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.
    Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ
    Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychedelic-assisted psychotherapy in palliative medicine].
    Schaller A; Bourquin G; Amorim Araujo I; Ljuslin M
    Rev Med Suisse; 2023 Dec; 19(855):2395-2398. PubMed ID: 38117108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.
    Yaden DB; Earp D; Graziosi M; Friedman-Wheeler D; Luoma JB; Johnson MW
    Front Psychol; 2022; 13():873279. PubMed ID: 35677124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing equity-oriented care in psychedelic medicine: Utilizing the EQUIP framework.
    Rea K; Wallace B
    Int J Drug Policy; 2021 Dec; 98():103429. PubMed ID: 34461409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy.
    Page LA; Rehman A; Syed H; Forcer K; Campbell G
    Front Psychiatry; 2021; 12():743599. PubMed ID: 35756728
    [No Abstract]   [Full Text] [Related]  

  • 18. The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.
    Berger JJ; Fitzgerald PB
    Australas Psychiatry; 2023 Apr; 31(2):190-194. PubMed ID: 36779819
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.